Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups

Objectives: The Xq28 region containing IRAK1 and MECP2 has been identified as a risk locus for systemic lupus erythematosus (SLE) in previous genetic association studies. However, due to the strong linkage disequilibrium between IRAK1 and MECP2, it remains unclear which gene is affected by the under...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2013
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22422
Acceso en línea:
https://doi.org/10.1136/annrheumdis-2012-201851
https://repository.urosario.edu.co/handle/10336/22422
Palabra clave:
Immunoglobulin enhancer binding protein
Interleukin 1 receptor associated kinase 1
Messenger rna
Methyl cpg binding protein 2
Amino acid substitution
Arhgap4 gene
Article
Asian
Avpr2 gene
Case control study
Chromosome xq
Chromosome xq28
Controlled study
Ethnic difference
European american
Gene
Gene location
Gene mapping
Genetic association
Genetic risk
Genetic susceptibility
Genotype
Haplotype
Hcfc1 gene
Hispanic
Human
Irak1 gene
L1cam gene
Major clinical study
Mecp2 gene
Naa10 gene
Negro
Plesiomorphy
Priority journal
Protein function
Real time polymerase chain reaction
Renbp gene
Single nucleotide polymorphism
Systemic lupus erythematosus
Tmem187 gene
Base sequence
Chromosome mapping
Continental population groups
Genetic predisposition to disease
Genotype
Haplotypes
Humans
Interleukin-1 receptor-associated kinases
Methyl-cpg-binding protein 2
Molecular sequence data
Real-time polymerase chain reaction
Risk factors
systemic
single nucleotide
human
Chromosomes
Lupus erythematosus
Polymorphism
Rights
License
Abierto (Texto Completo)
Description
Summary:Objectives: The Xq28 region containing IRAK1 and MECP2 has been identified as a risk locus for systemic lupus erythematosus (SLE) in previous genetic association studies. However, due to the strong linkage disequilibrium between IRAK1 and MECP2, it remains unclear which gene is affected by the underlying causal variant (s) conferring risk of SLE. Methods: We fine-mapped ?136 SNPs in a ?227 kb region on Xq28, containing IRAK1, MECP2 and seven adjacent genes (L1CAM, AVPR2, ARHGAP4, NAA10, RENBP HCFC1 and TMEM187), for association with SLE in 15 783 case-control subjects derived from four different ancestral groups. Results: Multiple SNPs showed strong association with SLE in European Americans, Asians and Hispanics at p and lt;5×10-8 with consistent association in subjects with African ancestry. Of these, six SNPs located in the TMEM187-IRAK1-MECP2 region captured the underlying causal variant(s) residing in a common risk haplotype shared by all four ancestral groups. Among them, rs1059702 best explained the Xq28 association signals in conditional testings and exhibited the strongest p value in transancestral meta-analysis (p meta=1.3×10-27, OR=1.43), and thus was considered to be the most likely causal variant. The risk allele of rs1059702 results in the amino acid substitution S196F in IRAK1 and had previously been shown to increase NF-KB activity in vitro. We also found that the homozygous risk genotype of rs1059702 was associated with lower mRNA levels of MECP2, but not IRAK1, in SLE patients (p=0.0012) and healthy controls (p=0.0064). Conclusions: These data suggest contributions of both IRAK1 and MECP2 to SLE susceptibility.